The reduction of time-to-market is a crucial competitive factor for pharmaceutical companies. The key to achieving this reduction is right-first-time testing (RFT). This approach prevents the production of faulty batches of medicinal products so that they are always within the required specifications.
Although manufacturers typically have a fixed process, there is still variability when it comes to raw materials, process conditions, operators, etc. The only way to determine whether the final formula is acceptable is to test it at the end of the process. The goal is to move away from this quality-by-inspection approach to quality-by-design and build an understanding of the quality into the process. Discover how process analytical technology saves time, reduces costs and ensures quality.